These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24948381)

  • 41. Lithium and GSK-3β promoter gene variants influence cortical gray matter volumes in bipolar disorder.
    Benedetti F; Poletti S; Radaelli D; Locatelli C; Pirovano A; Lorenzi C; Vai B; Bollettini I; Falini A; Smeraldi E; Colombo C
    Psychopharmacology (Berl); 2015 Apr; 232(7):1325-36. PubMed ID: 25345732
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of GSK-3β genetic variation with GSK-3β expression, prefrontal cortical thickness, prefrontal physiology, and schizophrenia.
    Blasi G; Napolitano F; Ursini G; Di Giorgio A; Caforio G; Taurisano P; Fazio L; Gelao B; Attrotto MT; Colagiorgio L; Todarello G; Piva F; Papazacharias A; Masellis R; Mancini M; Porcelli A; Romano R; Rampino A; Quarto T; Giulietti M; Lipska BK; Kleinman JE; Popolizio T; Weinberger DR; Usiello A; Bertolino A
    Am J Psychiatry; 2013 Aug; 170(8):868-76. PubMed ID: 23598903
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glycogen synthase kinase (GSK)-3beta levels and activity in a neurodevelopmental rat model of schizophrenia.
    Nadri C; Lipska BK; Kozlovsky N; Weinberger DR; Belmaker RH; Agam G
    Brain Res Dev Brain Res; 2003 Mar; 141(1-2):33-7. PubMed ID: 12644246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circadian rhythms and clock genes in psychotic disorders.
    Lamont EW; Coutu DL; Cermakian N; Boivin DB
    Isr J Psychiatry Relat Sci; 2010; 47(1):27-35. PubMed ID: 20686197
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic and clinical factors predict lithium's effects on PER2 gene expression rhythms in cells from bipolar disorder patients.
    McCarthy MJ; Wei H; Marnoy Z; Darvish RM; McPhie DL; Cohen BM; Welsh DK
    Transl Psychiatry; 2013 Oct; 3(10):e318. PubMed ID: 24150227
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic models in bipolar disorder: can the prediction of the long-term clinical course rely on the integration of clinical and molecular data?
    Pinna M; Manchia M
    Biomark Med; 2014; 8(3):371-4. PubMed ID: 24712426
    [No Abstract]   [Full Text] [Related]  

  • 47. Neuropsychiatric disorders: Shared genetics of bipolar disorder and schizophrenia.
    Potash JB; Bienvenu OJ
    Nat Rev Neurol; 2009 Jun; 5(6):299-300. PubMed ID: 19498428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structure-guided design of a highly selective glycogen synthase kinase-3β inhibitor: a superior neuroprotective pyrazolone showing antimania effects.
    Chen W; Gaisina IN; Gunosewoyo H; Malekiani SA; Hanania T; Kozikowski AP
    ChemMedChem; 2011 Sep; 6(9):1587-92. PubMed ID: 21751402
    [No Abstract]   [Full Text] [Related]  

  • 49. Failure to support a genetic contribution of AKT1 polymorphisms and altered AKT signaling in schizophrenia.
    Ide M; Ohnishi T; Murayama M; Matsumoto I; Yamada K; Iwayama Y; Dedova I; Toyota T; Asada T; Takashima A; Yoshikawa T
    J Neurochem; 2006 Oct; 99(1):277-87. PubMed ID: 16987250
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A specific group of patients with diagnostic conversion from depression to bipolar disorder and finally to dementia as a mental GSK-3 disease: A hypothesis.
    Terao T; Ishii N; Hirakawa H
    Bipolar Disord; 2020 Jun; 22(4):356-359. PubMed ID: 31742842
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Meta-analysis demonstrates lack of association of the GSK3B -50C/T polymorphism with risk of bipolar disorder.
    Chen G; Tang J; Yu G; Chen Y; Wang L; Zhang Y
    Mol Biol Rep; 2014 Sep; 41(9):5711-8. PubMed ID: 24929537
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic regulation of Nrxn1 [corrected] expression: an integrative cross-species analysis of schizophrenia candidate genes.
    Mozhui K; Wang X; Chen J; Mulligan MK; Li Z; Ingles J; Chen X; Lu L; Williams RW
    Transl Psychiatry; 2011 Jul; 1(7):e25. PubMed ID: 22832527
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunohistochemical localization of glycogen synthase and GSK3β: control of glycogen content in retina.
    Pérezleón JA; Osorio-Paz I; Francois L; Salceda R
    Neurochem Res; 2013 May; 38(5):1063-9. PubMed ID: 23512644
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response.
    Souza RP; Romano-Silva MA; Lieberman JA; Meltzer HY; Wong AH; Kennedy JL
    Psychopharmacology (Berl); 2008 Oct; 200(2):177-86. PubMed ID: 18500637
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic variability at IMPA2, INPP1 and GSK3β increases the risk of suicidal behavior in bipolar patients.
    Jiménez E; Arias B; Mitjans M; Goikolea JM; Roda E; Sáiz PA; García-Portilla MP; Burón P; Bobes J; Oquendo MA; Vieta E; Benabarre A
    Eur Neuropsychopharmacol; 2013 Nov; 23(11):1452-62. PubMed ID: 23453640
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glycogen synthase kinase-3beta, beta-catenin, and tau in postmortem bipolar brain.
    Lesort M; Greendorfer A; Stockmeier C; Johnson GV; Jope RS
    J Neural Transm (Vienna); 1999; 106(11-12):1217-22. PubMed ID: 10651115
    [TBL] [Abstract][Full Text] [Related]  

  • 57. GSK3beta, a centre-staged kinase in neuropsychiatric disorders, modulates long term memory by inhibitory phosphorylation at serine-9.
    Dewachter I; Ris L; Jaworski T; Seymour CM; Kremer A; Borghgraef P; De Vijver H; Godaux E; Van Leuven F
    Neurobiol Dis; 2009 Aug; 35(2):193-200. PubMed ID: 19379814
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The potential of genetic and gene expression analysis in the diagnosis of neuropsychiatric disorders.
    van de Leemput J; Glatt SJ; Tsuang MT
    Expert Rev Mol Diagn; 2016 Jun; 16(6):677-95. PubMed ID: 27017833
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glycogen synthase kinase-3 beta and tau genes interact in Parkinson's and Alzheimer's diseases.
    García-Gorostiaga I; Sánchez-Juan P; Mateo I; Rodríguez-Rodríguez E; Sánchez-Quintana C; del Olmo SC; Vázquez-Higuera JL; Berciano J; Combarros O; Infante J
    Ann Neurol; 2009 Jun; 65(6):759-61; author reply 761-2. PubMed ID: 19557862
    [No Abstract]   [Full Text] [Related]  

  • 60. DISC1: a schizophrenia gene with multiple personalities.
    Wexler EM; Geschwind DH
    Neuron; 2011 Nov; 72(4):501-3. PubMed ID: 22099453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.